Skin maintained ex vivo, hyaluronic acid expression (basal)| Type of assay | GAG synthesis | | Biological model | Skin (ex vivo) | | Species | Human | | Endpoint | Hyaluronic acid immunolabeling |
| SKIN-0010 | Epidermal matrix, hydration | GAG synthesis | Skin (ex vivo) | Human | Hyaluronic acid immunolabeling | Immunohistofluorescence | Basal | |
RHE, hyaluronic acid synthesis / release (basal)| Type of assay | GAG synthesis | | Biological model | Reconstructed Epidermis, BIOalternatives RHE | | Species | Human | | Endpoint | Hyaluronic acid synthesis / release |
| EPIBA-0028 | Epidermal matrix, hydration | GAG synthesis | Reconstructed Epidermis, BIOalternatives RHE | Human | Hyaluronic acid synthesis / release | ELISA / EIA | Basal | |
RHE, total GAGs neosynthesis (basal)| Type of assay | GAG synthesis | | Biological model | Reconstructed Epidermis, BIOalternatives RHE | | Species | Human | | Endpoint | Glycosaminoglycans (GAGs, total) |
| EPIBA-0029 | Epidermal matrix, hydration | GAG synthesis | Reconstructed Epidermis, BIOalternatives RHE | Human | Glycosaminoglycans (GAGs, total) | [3H]-glucosamine incorporation | Basal | |
RHE, sulfated GAGs neosynthesis (basal)| Type of assay | GAG synthesis | | Biological model | Reconstructed Epidermis, BIOalternatives RHE | | Species | Human | | Endpoint | Sulfated glycosaminoglycans (sulfated GAGs) |
| EPIBA-0030 | Epidermal matrix, hydration | GAG synthesis | Reconstructed Epidermis, BIOalternatives RHE | Human | Sulfated glycosaminoglycans (sulfated GAGs) | Sulfur-35 (35S) incorporation | Basal | |
NHEK, hyaluronic acid synthesis / release (basal)| Type of assay | GAG synthesis | | Biological model | Epidermal keratinocytes (NHEK) | | Species | Human | | Endpoint | Hyaluronic acid synthesis / release |
| NHEK-0066 | Epidermal matrix, hydration | GAG synthesis | Epidermal keratinocytes (NHEK) | Human | Hyaluronic acid synthesis / release | ELISA / EIA | Basal | |
NHEK, total GAGs neosynthesis (basal)| Type of assay | GAG synthesis | | Biological model | Epidermal keratinocytes (NHEK) | | Species | Human | | Endpoint | Glycosaminoglycans (GAGs, total) |
| NHEK-0067 | Epidermal matrix, hydration | GAG synthesis | Epidermal keratinocytes (NHEK) | Human | Glycosaminoglycans (GAGs, total) | [3H]-glucosamine incorporation | Basal | |
NHEK, sulfated GAGs neosynthesis (basal)| Type of assay | GAG synthesis | | Biological model | Epidermal keratinocytes (NHEK) | | Species | Human | | Endpoint | Sulfated glycosaminoglycans (sulfated GAGs) |
| NHEK-0068 | Epidermal matrix, hydration | GAG synthesis | Epidermal keratinocytes (NHEK) | Human | Sulfated glycosaminoglycans (sulfated GAGs) | Sulfur-35 (35S) incorporation | Basal | |
